文献速递结核与非结核分枝杆菌艾滋病与性传播感染

肺结核治疗失败临床预测模型的开发与验证

A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.
PubMed 文献 · Clin Infect Dis · 2022-01-01

基于巴西前瞻性观察队列中944例培养确诊、药物敏感肺结核患者,开发了包含血红蛋白、HIV感染、药物使用、糖尿病、年龄、教育程度和吸烟7个基线预测因子的治疗失败预测模型,模型区分度良好(c-statistic=0.77),HIV相关因素和异烟肼乙酰化状态未改善预测。

要点

  • 7个基线预测因子可预测肺结核治疗失败风险
  • 模型区分度良好,c-statistic=0.77
  • HIV相关因素和异烟肼乙酰化状态未提升预测能力

核心结论

  • 使用治疗开始时即可获得的信息构建的预测模型在该人群中表现良好,可指导资源分配或为高危患者制定针对性干预。

研究设计与样本

  • 数据来自巴西Regional Prospective Observational Research for Tuberculosis队列,2015至2019年入组新诊断TB患者;分析纳入培养确诊、药物敏感肺结核、开始一线抗TB治疗且随访≥12个月者,共944例;缺失预测因子采用插补,通过bootstrap后向选择确定预测因子,以c-statistic和校准图评价区分度与校准,bootstrap内部验证估计过拟合并应用收缩因子。

主要发现

  • 944例中191例(20%)出现治疗失败结局;最终模型纳入7个基线预测因子:血红蛋白、HIV感染、药物使用、糖尿病、年龄、教育程度和吸烟;模型区分度良好(c-statistic=0.77;95%CI .73-.80),校准良好(乐观校正截距和斜率分别为-0.12和0.89);HIV相关因素和异烟肼乙酰化状态未改善最终模型的预测。

关键数值与推荐

  • 终点为治疗失败复合结局:死亡、治疗失败、方案更换、治疗不完整或未评估;模型区分度c-statistic=0.77(95%CI .73-.80);乐观校正截距-0.12、斜率0.89。

临床怎么用

  • 在治疗开始时利用常规可得的7项基线指标识别治疗失败高危患者,辅助资源分配和针对性干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite widespread availability of curative therapy, tuberculosis (TB) treatment outcomes remain suboptimal. Clinical prediction models can inform treatment strategies to improve outcomes. Using baseline clinical data, we developed a prediction model for unsuccessful TB treatment outcome and evaluated the incremental value of human immunodeficiency virus (HIV)-related severity and isoniazid acetylator status. METHODS: Data originated from the Regional Prospective Observational Research for Tuberculosis Brazil cohort, which enrolled newly diagnosed TB patients in Brazil from 2015 through 2019. This analysis included participants with culture-confirmed, drug-susceptible pulmonary TB who started first-line anti-TB therapy and had ≥12 months of follow-up. The end point was unsuccessful TB treatment: composite of death, treatment failure, regimen switch, incomplete treatment, or not evaluated. Missing predictors were imputed. Predictors were chosen via bootstrapped backward selection. Discrimination and calibration were evaluated with c-statistics and calibration plots, respectively. Bootstrap internal validation estimated overfitting, and a shrinkage factor was applied to improve out-of-sample prediction. Incremental value was evaluated with likelihood ratio-based measures. RESULTS: Of 944 participants, 191 (20%) had unsuccessful treatment outcomes. The final model included 7 baseline predictors: hemoglobin, HIV infection, drug use, diabetes, age, education, and tobacco use. The model demonstrated good discrimination (c-statistic = 0.77; 95% confidence interval, .73-.80) and was well calibrated (optimism-corrected intercept and slope, -0.12 and 0.89, respectively). HIV-related factors and isoniazid acetylation status did not improve prediction of the final model. CONCLUSIONS: Using information readily available at treatment initiation, the prediction model performed well in this population. The findings may guide future work to allocate resources or inform targeted interventions for high-risk patients.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Peetluk LS, Rebeiro PF, Ridolfi FM, et al. A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes. Clin Infect Dis. 2022. PMID: 34214166. doi:10.1093/cid/ciab598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。